Rotavirus Genotypes over Time in Vaccine-Introducing and Non-Introducing Countries
1 of 10
Evaluation of the Indirect Effects of Rotavirus Vaccination Programs in World Health Organization Member States
2 of 10
The Impact of Rotavirus Vaccine Introduction: An Exploratory Analysis of Case Statistics in Kenya, Zimbabwe and Senegal
3 of 10
Multi-scale assessment of rotavirus vaccination: determinants of immunological, clinical and population-level effects
4 of 10
Rotavirus Vaccines and Health Care Utilization for Rotavirus and Diarrhea in the United States (2007-2014)
5 of 10
BARRIERS TO TIMELY COMPLETION OF ROTAVIRUS IMMUNIZATION SERIES IN
EL ALTO, BOLIVIA
6 of 10
Norovirus and Rotavirus Prevalence in Pediatric Patients with
Underlying Gastrointestinal Dysfunction in Atlanta, GA, 2012-2013
7 of 10
The Roles of Microbiota and Innate Immunity during Rotavirus
Infection and Humoral Immunity
8 of 10
Norovirus and Rotavirus Prevalence in Immunocompromised Patients
and Nosocomial Infections in Egleston and Scottish Rite Children's
Hospitals in Atlanta, GA
9 of 10
Trace elements, inflammation, and rotavirus vaccine response among a cohort of infants in El Alto, Bolivia